CochLear Ltd. Unsponsored ADR (CHEOY)
(Delayed Data from OTC)
$100.71 USD
-0.68 (-0.67%)
Updated Aug 28, 2024 02:42 PM ET
5-Strong Sell of 5 5
F Value B Growth A Momentum D VGM
Income Statements
Fiscal Year end for CochLear Ltd Unsponsored ADR falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 1,488 | 1,303 | 1,196 | 1,153 | 887 |
Cost Of Goods | NA | 329 | 298 | NA | NA |
Gross Profit | NA | 975 | 898 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 713 | 607 | 0 | 0 |
Income After Depreciation & Amortization | 0 | 262 | 290 | 0 | 0 |
Non-Operating Income | NA | 11 | 2 | NA | NA |
Interest Expense | NA | 6 | 6 | NA | NA |
Pretax Income | NA | 267 | 286 | NA | NA |
Income Taxes | NA | 65 | 76 | NA | NA |
Minority Interest | NA | 0 | 0 | NA | NA |
Investment Gains/Losses | NA | 0 | 0 | NA | NA |
Other Income/Charges | NA | 0 | 0 | NA | NA |
Income From Cont. Operations | 235 | 202 | 210 | 251 | -160 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 235 | 202 | 210 | 251 | -160 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 317 | 343 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | NA | 54 | 53 | NA | NA |
Income After Depreciation & Amortization | 0 | 262 | 290 | 0 | 0 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 131.06 | 131.55 | 131.59 | 131.47 | 119.27 |
Diluted EPS Before Non-Recurring Items | 1.94 | 1.56 | 1.53 | 1.39 | 0.87 |
Diluted Net EPS (GAAP) | 1.79 | 1.54 | 1.59 | 1.91 | -1.34 |
Fiscal Year end for CochLear Ltd Unsponsored ADR falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |